BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Dong C, Zhou H, Shen C, Yu LG, Ding Y, Zhang YH, Guo ZR. Role of peroxisome proliferator-activated receptors gene polymorphisms in type 2 diabetes and metabolic syndrome. World J Diabetes 2015; 6(4): 654-661 [PMID: 25987964 DOI: 10.4239/wjd.v6.i4.654]
URL: https://www.wjgnet.com/1948-9358/full/v6/i4/654.htm
Number Citing Articles
1
Mahmoud M. Sirdah, N. Scott Reading. Genetic predisposition in type 2 diabetes: A promising approach toward a personalized management of diabetesClinical Genetics 2020; 98(6) doi: 10.1111/cge.13772
2
Yubing Huang, Yuhang Zhu, Zhaoqiong Zhu. Recent Advancements in the Research of the Mechanism by Which PPAR‐γ Is Involved in Postoperative Neurocognitive DisorderThe FASEB Journal 2025; 39(22) doi: 10.1096/fj.202502727R
3
Hussan Munir, Sanabil Yaqoob, Kanza Aziz Awan, Aysha Imtiaz, Hiba Naveed, Naveed Ahmad, Muhammad Naeem, Waleed Sultan, Yongkun Ma. Unveiling the Chemistry of Citrus Peel: Insights into Nutraceutical Potential and Therapeutic ApplicationsFoods 2024; 13(11) doi: 10.3390/foods13111681
4
Wang-Soo Lee, Jaetaek Kim. Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future DirectionsPPAR Research 2015; 2015 doi: 10.1155/2015/271983
5
Razwa Saleh, Zahidul Islam Zahid, Mohammad Atikur Rahman, Preeti Jain, Ashraful Alam, Masashi Kawaichi, Hasan Mahmud Reza. Prevalence of PPAR-γ2 (rs1801282), RETN (rs3745367) and ADIPOQ (rs2241766) SNP markers in the Bangladeshi type 2 diabetic populationMeta Gene 2016; 10 doi: 10.1016/j.mgene.2016.08.002
6
Ekrem AKBULUT, Metin ÖZGEN. Contribution of polymorphism in the non-coding region of PPARα to the development of axial spondyloarthritisAdıyaman University Journal of Science 2020;  doi: 10.37094/adyujsci.650677
7
Mehdi Hatami, Massoud Saidijam, Reza Yadegarzari, Shiva Borzuei, Alireza Soltanian, Marzieh Safi Arian, Mohammad Taghi Goodarzi. Peroxisome Proliferator-Activated Receptor-γGene Expression and Its Association with Oxidative Stress in Patients with Metabolic SyndromeChonnam Medical Journal 2016; 52(3) doi: 10.4068/cmj.2016.52.3.201
8
Sunaina Gautam, Shivani Kumari, Deepika Misra, Naveen Kumar Gautam. WITHDRAWN: PPARγ: A Key to Personalized TreatmentAspects of Molecular Medicine 2025;  doi: 10.1016/j.amolm.2025.100081
9
Aman Upaganlawar, Chandrashekhar Upasani, Stella Amarachi Ihim. Current Thoughts on Dementia2022;  doi: 10.1007/978-981-16-7606-2_14
10
Sarah O'Connor, Iwona Rudkowska. Advances in Food and Nutrition Research 2019; 87 doi: 10.1016/bs.afnr.2018.07.004
11
Joanna Rzemieniec, Laura Castiglioni, Paolo Gelosa, Majeda Muluhie, Benedetta Mercuriali, Luigi Sironi. Nuclear Receptors in Myocardial and Cerebral Ischemia—Mechanisms of Action and Therapeutic StrategiesInternational Journal of Molecular Sciences 2021; 22(22) doi: 10.3390/ijms222212326
12
Huang-Jun Liu, Hai-Han Liao, Zheng Yang, Qi-Zhu Tang. Peroxisome Proliferator-Activated Receptor-γIs Critical to Cardiac FibrosisPPAR Research 2016; 2016 doi: 10.1155/2016/2198645
13
N. R. Harvey, S. Voisin, P. J. Dunn, H. Sutherland, X. Yan, M. Jacques, I. D. Papadimitriou, L. J. Haseler, K. J. Ashton, L. M. Haupt, N. Eynon, L. R. Griffiths. Genetic variants associated with exercise performance in both moderately trained and highly trained individualsMolecular Genetics and Genomics 2020; 295(2) doi: 10.1007/s00438-019-01639-8
14
Amin Mirrafiei, Mohaddeseh Hasanzadeh, Fatemeh Sheikhhossein, Maryam Majdi¹, Kurosh Djafarian, Sakineh Shab-Bidar. Association of main meal quality index with the odds of metabolic syndrome in Iranian adults: a cross-sectional studyBMC Nutrition 2023; 9(1) doi: 10.1186/s40795-023-00711-2
15
IJ Bage, S Kamalanathan, S Selvarajan, J Sahoo, J Mathaiyan, D Naik. Peroxisome Proliferator-Activated Receptor α and γ Gene Polymorphisms among South Indian Patients with Diabetic DyslipidaemiaIndian Journal of Endocrinology and Metabolism 2023; 27(2) doi: 10.4103/ijem.ijem_451_22
16
Sunaina Gautam, Shivani Kumari, Deepika Misra, Naveen Kumar Gautam. Molecular insights into PPAR-γ: genetic variations exploring association with diabetes and related complications and their role in antidiabetic drug response— A comprehensive reviewInternational Journal of Diabetes in Developing Countries 2026;  doi: 10.1007/s13410-026-01662-7
17
Jing Yang, Yumeng Chen, Haiyang Luan, Jingwen Li, Wei Liu. Persistent impairment of gonadal development in rare minnow (Gobiocypris rarus) after chronic exposure to chlorinated polyfluorinated ether sulfonateAquatic Toxicology 2022; 250 doi: 10.1016/j.aquatox.2022.106256
18
Ayokunle O. Ademosun, Ganiyu Oboh, Tosin A. Olasehinde, Opeyemi O. Adeoyo. From folk medicine to functional food: a review on the bioactive components and pharmacological properties of citrus peelsOriental Pharmacy and Experimental Medicine 2018; 18(1) doi: 10.1007/s13596-017-0292-8
19
Xiaoping Han, Ying Geng, Yifang Li, Xianglong Meng, Jian Jiao. Roles of peroxisome proliferator-activated receptors (PPARs) in pancreatic metabolic diseasesPharmacological Research 2026; 227 doi: 10.1016/j.phrs.2026.108192
20
Anna Andrzejczak, Agata Witkowicz, Dorota Kujawa, Damian Skrypnik, Monika Szulińska, Paweł Bogdański, Łukasz Łaczmański, Lidia Karabon. NGS Sequencing Reveals New UCP1 Gene Variants Potentially Associated with MetS and/or T2DM Risk in the Polish Population—A Preliminary StudyGenes 2023; 14(4) doi: 10.3390/genes14040789
21
M.R. Barbieri, A.M. Fontes, M.A. Barbieri, M.C.P. Saraiva, V.M.F. Simões, A.A.M. da Silva, K.J. Abraham, H. Bettiol. Effects of FTO and PPARγ variants on intrauterine growth restriction in a Brazilian birth cohortBrazilian Journal of Medical and Biological Research 2021; 54(1) doi: 10.1590/1414-431x202010465
22
Anna Skoczyńska, Monika Ołdakowska, Agnieszka Dobosz, Rajmund Adamiec, Sofya Gritskevich, Anna Jonkisz, Arleta Lebioda, Joanna Adamiec-Mroczek, Małgorzata Małodobra-Mazur, Tadeusz Dobosz. PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical ExperimentsBiomolecules 2024; 14(7) doi: 10.3390/biom14070786
23
Abdelrahman Ibrahim Abushouk, Mostafa Wanees Ahmed El-Husseny, Eshak I. Bahbah, Ahmed Elmaraezy, Aya Ashraf Ali, Asmaa Ashraf, Mohamed M. Abdel-Daim. Peroxisome proliferator-activated receptors as therapeutic targets for heart failureBiomedicine & Pharmacotherapy 2017; 95 doi: 10.1016/j.biopha.2017.08.083
24
Stanislav Alexandra Alina. The identification of the high risk of metabolic syndrome by applying MDR and Jalview bioinformatics programsPharmacy & Pharmacology International Journal 2020; 8(3) doi: 10.15406/ppij.2020.08.00290
25
Jing‐Ru Weng, Li‐Yuan Bai, Wei‐Yu Lin. Identification of a Triterpenoid as a Novel PPARγ Activator Derived from Formosan PlantsPhytotherapy Research 2017; 31(11) doi: 10.1002/ptr.5900
26
Dilip K Yadav, Smeeta Shrestha, Gunjan Dadhwal, Giriraj R Chandak. Identification and Characterization of Cis -Regulatory Elements ‘Insulator and Repressor’ in PPARD Gene Epigenomics 2018; 10(5) doi: 10.2217/epi-2017-0139
27
Célia Lopes, Tânia Vieira Madureira, Nádia Ferreira, Ivone Pinheiro, L. Filipe C. Castro, Eduardo Rocha. Peroxisome proliferator-activated receptor gamma (PPARγ) in brown trout: Interference of estrogenic and androgenic inputs in primary hepatocytesEnvironmental Toxicology and Pharmacology 2016; 46 doi: 10.1016/j.etap.2016.08.009
28
Soaad Alfaqaan, Tomoki Yoshida, Hiromi Imamura, Chihiro Tsukano, Yoshiji Takemoto, Akira Kakizuka. PPARα-Mediated Positive-Feedback Loop Contributes to Cold Exposure MemoryScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-40633-3
29
Xiang Zhang, Yarong Hao. <p>Beneficial Effects of Echinacoside on Diabetic Cardiomyopathy in Diabetic <em>Db/Db</em> Mice</p>Drug Design, Development and Therapy 2020;  doi: 10.2147/DDDT.S276972
30
Lizhi Tang, Qingguo Lü, Hongyi Cao, Qiu Yang, Nanwei Tong. PPARD rs2016520 polymorphism is associated with metabolic traits in a large population of Chinese adultsGene 2016; 585(2) doi: 10.1016/j.gene.2016.02.035